271 related articles for article (PubMed ID: 20584856)
1. Translational promise of the apelin--APJ system.
Barnes G; Japp AG; Newby DE
Heart; 2010 Jul; 96(13):1011-6. PubMed ID: 20584856
[TBL] [Abstract][Full Text] [Related]
2. Apelin and its receptor APJ in cardiovascular diseases.
Yu XH; Tang ZB; Liu LJ; Qian H; Tang SL; Zhang DW; Tian GP; Tang CK
Clin Chim Acta; 2014 Jan; 428():1-8. PubMed ID: 24055369
[TBL] [Abstract][Full Text] [Related]
3. Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure.
Barnes GD; Alam S; Carter G; Pedersen CM; Lee KM; Hubbard TJ; Veitch S; Jeong H; White A; Cruden NL; Huson L; Japp AG; Newby DE
Circ Heart Fail; 2013 May; 6(3):482-91. PubMed ID: 23519586
[TBL] [Abstract][Full Text] [Related]
4. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential.
Japp AG; Newby DE
Biochem Pharmacol; 2008 May; 75(10):1882-92. PubMed ID: 18272138
[TBL] [Abstract][Full Text] [Related]
5. Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target.
Falcão-Pires I; Leite-Moreira AF
Rev Port Cardiol; 2005 Oct; 24(10):1263-76. PubMed ID: 16398242
[TBL] [Abstract][Full Text] [Related]
6. In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure.
Sheikh AY; Chun HJ; Glassford AJ; Kundu RK; Kutschka I; Ardigo D; Hendry SL; Wagner RA; Chen MM; Ali ZA; Yue P; Huynh DT; Connolly AJ; Pelletier MP; Tsao PS; Robbins RC; Quertermous T
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H88-98. PubMed ID: 17906101
[TBL] [Abstract][Full Text] [Related]
7. Apelin and ACE2 in cardiovascular disease.
Kalea AZ; Batlle D
Curr Opin Investig Drugs; 2010 Mar; 11(3):273-82. PubMed ID: 20178040
[TBL] [Abstract][Full Text] [Related]
8. Apelin/APJ system: a promising therapy target for hypertension.
Wu D; He L; Chen L
Mol Biol Rep; 2014 Oct; 41(10):6691-703. PubMed ID: 24990699
[TBL] [Abstract][Full Text] [Related]
9. Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development.
Kang Y; Kim J; Anderson JP; Wu J; Gleim SR; Kundu RK; McLean DL; Kim JD; Park H; Jin SW; Hwa J; Quertermous T; Chun HJ
Circ Res; 2013 Jun; 113(1):22-31. PubMed ID: 23603510
[TBL] [Abstract][Full Text] [Related]
10. Apelin is a positive regulator of ACE2 in failing hearts.
Sato T; Suzuki T; Watanabe H; Kadowaki A; Fukamizu A; Liu PP; Kimura A; Ito H; Penninger JM; Imai Y; Kuba K
J Clin Invest; 2013 Dec; 123(12):5203-11. PubMed ID: 24177423
[TBL] [Abstract][Full Text] [Related]
11. [The functional role of endogenous APJ agonists; Apelin and Elabela/Toddler in cardiovascular diseases].
Sato T; Kuba K
Nihon Yakurigaku Zasshi; 2019; 153(4):172-178. PubMed ID: 30971657
[TBL] [Abstract][Full Text] [Related]
12. Endogenous regulation of cardiovascular function by apelin-APJ.
Charo DN; Ho M; Fajardo G; Kawana M; Kundu RK; Sheikh AY; Finsterbach TP; Leeper NJ; Ernst KV; Chen MM; Ho YD; Chun HJ; Bernstein D; Ashley EA; Quertermous T
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1904-13. PubMed ID: 19767528
[TBL] [Abstract][Full Text] [Related]
13. [The role of apelin in pathogenesis of cardiovascular diseases and metabolic disorders].
Cudnoch Jędrzejewska A; Czarzasta K; Gomółka R; Szczepańska Sadowska E
Kardiol Pol; 2011; 69 Suppl 3():89-93. PubMed ID: 22125210
[TBL] [Abstract][Full Text] [Related]
14. Expanding role for the apelin/APJ system in physiopathology.
Carpéné C; Dray C; Attané C; Valet P; Portillo MP; Churruca I; Milagro FI; Castan-Laurell I
J Physiol Biochem; 2007 Dec; 63(4):359-73. PubMed ID: 18457011
[TBL] [Abstract][Full Text] [Related]
15. The Emerging Potential of the Apelin-APJ System in Heart Failure.
Dalzell JR; Rocchiccioli JP; Weir RA; Jackson CE; Padmanabhan N; Gardner RS; Petrie MC; McMurray JJ
J Card Fail; 2015 Jun; 21(6):489-98. PubMed ID: 25795508
[TBL] [Abstract][Full Text] [Related]
16. Putative role for apelin in pressure/volume homeostasis and cardiovascular disease.
Charles CJ
Cardiovasc Hematol Agents Med Chem; 2007 Jan; 5(1):1-10. PubMed ID: 17266543
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of downregulation of the apelin-APJ system in doxorubicin-induced cardiotoxicity.
Hamada J; Baasanjav A; Ono N; Murata K; Kako K; Ishida J; Fukamizu A
Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H931-41. PubMed ID: 25681427
[TBL] [Abstract][Full Text] [Related]
18. Emerging roles of apelin in biology and medicine.
Kleinz MJ; Davenport AP
Pharmacol Ther; 2005 Aug; 107(2):198-211. PubMed ID: 15907343
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin.
Medhurst AD; Jennings CA; Robbins MJ; Davis RP; Ellis C; Winborn KY; Lawrie KW; Hervieu G; Riley G; Bolaky JE; Herrity NC; Murdock P; Darker JG
J Neurochem; 2003 Mar; 84(5):1162-72. PubMed ID: 12603839
[TBL] [Abstract][Full Text] [Related]
20. Expression of the apelin-APJ pathway and effects on erectile function in a mouse model of vasculogenic erectile dysfunction.
Kwon MH; Tuvshintur B; Kim WJ; Jin HR; Yin GN; Song KM; Choi MJ; Kwon KD; Batbold D; Ryu JK; Suh JK
J Sex Med; 2013 Dec; 10(12):2928-41. PubMed ID: 23578329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
